Objectives There is a resurgence of interest in lung-sparing extirpative surgery for malignant pleural mesothelioma with recent reports of better survival and fewer adverse consequences than with extrapleural pneumonectomy. However, these operations are not well-characterized and to offer evidence-based clinical recommendations and to plan future trials a summary of what is already known is required.
Introduction
The incidence of malignant pleural mesothelioma (MPM) in Europe is still rising and Britain has the highest mesothelioma death rate in the world. Asbestos exposure was at its greatest between 1950 and 1970 and death rates are expected to peak in the next few years mirroring the pattern of asbestos imports. [1] [2] [3] The number of cases of the disease faced in Europe as a whole is high and there is an incalculable burden of disease expected in the less developed world. .$%#'"(#% '&89&:&; "<; %=9#"$>& %#=;9&% 9;&<#9?9&; ?@' '&#'9&8"> @? ?=>> A=$>9("#9@< ?@' ;&#"9>&; '&89&:
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No part of this practice was subjected to randomized trial prior to the Mesothelioma and Radical Surgery (MARS) trial. Extrapleural pneumonectomy (EPP) accompanied by adjuvant therapy was regarded as offering the best prospect of prolonged survival following Sugarbaker's report about 10 years ago 4 but a large multivariate analysis comparing the results of EPP with pleurectomy/decorticiaton (PD) has since shown better survival for the lung sparing form of surgery. 5 It was stressed by the authors that this difference in favour of PD was despite the observation that the group undergoing PD were considered to have a relatively worse prognosis and to be less favourable cases for surgery. 5 At the same time there has been an increased interest in PD [6] [7] [8] and it is given prominence in recent European guidelines. 9 In the literature a range of terms appear but pleurectomy/decortication appears in both European 9 and American guidance. 10 Pleurectomy may be termed partial, total or radical while the relative incompleteness of the extirpation of the cancer is signified by terms such as debulking, occasionally cytoreduction, and increasingly by the term macroscopic complete resection. What these operations have in common is that they are all extirpative surgery for mesothelioma, which does not include pneumonectomy. It is this surgery that is the subject of this systematic review.
Materials and methods
The literature was searched using a formal strategy (Appendix 1 -see http://jrsm.rsmjournals.com/ cgi/content/full/jrsm.2010.100345/DC1). Manuscript titles were searched to identify papers that might include data concerning survival following non-EPP surgery for mesothelioma, with or without multimodality treatment. Papers excluded at the first selection (ET,CT) were teaching and review articles, technical reports, and those containing no relevant data concerning surgical treatment. A further selection was made to remove any registries that overlapped with institutional reports and single institutional studies that were superseded by later reports from the same institution (ET, TT). Obvious exclusions were made on the basis of abstracts, and further exclusions after reading 58 full articles ( Figure 1 ). To exclude any selection bias, decisions about inclusions and exclusions were made in discussion between all four authors before any analysis or data synthesis, purely on the basis of whether usable data could be extracted.
Papers were individually searched and data extracted (ET) and all data included in analyses were confirmed in working sessions with two or more of the authors working together (ET, FF, TT). We looked for the start and end dates of the reported series, the number of patients reported, sex, age, tumour histology, stage, asbestos exposure, laterality, type of surgery performed, any adjuvant therapy, all survival data available, respiratory outcomes, and patterns of recurrence. We performed a textual analysis of the descriptions of operations performed. We constructed evidence tables and created graphical displays of aggregated and discrete data as appropriate.
Results
The search resulted in 464 titles which by various inclusion/exclusion processes resulted in 26 papers containing data on lung-sparing surgery ( Figure 1 ). 5, 7, 8, There were no randomized trials or studies comparing the outcomes of surgery with a non-operated control group. The reports were heterogeneous, some reporting various forms of surgery within the same report and others reporting surgical patients within an overall experience including non-operated patients. This made analysis difficult so we have been careful not A total of 1270 patients are included in the reports used in the analysis although the number incorporated varies from one data summary to another because data were not available for every analysis in all papers. The (weighted) mean age in the whole series was 62 years. The average age shows a small upward trend over the 30 years of reported data but the age range of patients included is essentially unchanging over 25 years of reporting ( Figure 2 ). Male patients are in the majority in all reports with an average of 80% men.
Asbestos exposure was recorded in 13 papers 7, 8, 13, 16, 17, 21, 22, 24, 25, 27, [31] [32] [33] and was positive in 64% of patients (682/1061 patients) with a range of 17-95%. The rate in some reports is given for all mesothelioma patients, not just those operated. The variation in the asbestos exposure rate is more likely to be attributable to the assiduity of recording rather than a real epidemiological variation.
In four reports 5, [11] [12] [13] including 564 patients (individual series included 15, 26, 245 and 278 patients) 60% had right-sided disease with the proportion ranging from 52-62% for the four series included. This is consistent and the difference between right and left may simply reflect the relative surface area of pleura at risk.
In 14 reports 8, 12, 13, 17, 22, 24, 26 the breakdown of operated patients by histology is provided ( Figure  3 ). The dominance of epithelioid type is evident. The report of Clarke et al. 14 is an outlier by virtue of the large number of mixed tumours reported. It is relatively recent and from a group with a large experience and may illustrate a recognition that the dichotomy for epithelioid versus sarcomatoid histology is often not possible.
In seven reports 8, 20, 21, 24, 25, 31, 32 there is a breakdown by stage of operated patients ( Table 1) . The staging systems have varied over time and are more comprehensively reported in some recent papers, for example in 2008 by Nakas. 8 The authors state 'The patients that had radical P/D were staged according to the WHO and IMIG staging systems but this was not appropriate for group NR [non-radical]'. Use of a different staging system for different operations clearly represented a warning to us as we considered how to aggregate data. It is also likely from the table that in later series 8, 21, 23 higher stage patients are planned for PD (lower stage being offered EPP) while earlier more of the lower (more selected) stage patients had surgery in the form of PD. There is likely to be deliberate selection of different types of patients, depending on whether the group offered either or both operations at the time, making further analysis unlikely to be informative. As an illustration of the potential for over interpretation of data to mislead, consider Table 1 . There is an impression of relatively longer survival with increasing proportion of advanced stage. Further analysis along these lines would be unlikely to add useful knowledge about the role of PD in the management of mesothelioma patients and whether it is more appropriate in one pathological stage than in another. A textual analysis of the nature of surgery described in these 26 reports is summarized in Table 2 where the papers are presented in chronological order of publication. Where authors give discrete descriptions of more than one form of lungsparing surgery, they appear in separate rows. It is evident that there is considerable variation in the surgery performed. Most authors use the word 'pleurectomy' but it is often qualified as total, radical, non-radical, sub-total or partial. 'Decortication' is less often used but descriptions of surgery become more detailed over time and the abbreviation P/D for pleurectomy and decortication appears more recently. In many of these publications a mixture of operations are reported and we have only extracted data on PD in this paper. Sometimes there was a gradation in the surgery performed: in some reports if EPP was the intention but intrapoperatively that surgery could not be performed, these patients had some other, presumably lesser, but not always well characterized, form of surgery. For example, Allen gives a long and very detailed description of extrapleural pneumonectomy but if, for any of a number of patient or pathological factors, EPP was precluded in their view, the surgery performed was categorized by the one word, pleurectomy. 27 There is a consistent theme of modifying the operation according to the intra-operative findings. In earlier papers this tended towards conservativism, non-radical, sparing the diaphragm, sparing the mediastinal pleura and with a textual reminder that the surgery has a palliative intent. For example 'A lesser procedure such as decortication/pleurectomy was considered for locally extensive disease but only for relief of pain or shortness of breath'. 'The aim of this procedure was to attempt palliation of troublesome symptoms particularly chest pain and pleural effusion.' 21 In some, particularly more recent series, PD is performed with radical intent. 8 We judge that resection of the diaphragm or pericardium was infrequently performed in early series because it is specifically mentioned if done 16, 31, 32 whereas it is included in the general operative description in more recent reports. 5, 8, 11, 13 It appears that it was optional with a degree of selection for appropriateness but it is often unclear in how many patients these steps were taken ( Table 2) .
The operative mortality, 1, 2, 3, 4 and 5-year survival, and median survival are given in Table 3 . Some data were as supplied by the authors in text or tables and some were read from their figures. The survival data at each year from first to fifth are illustrated graphically with symbols weighted by the number of patients in the series (<25, 25-49, 50-99, >99) ( Figure 4 ). To explore any trend in outcome over time, for 22 reports where the median survival and the start and end dates of the clinical series are provided, the data are presented graphically in Figure 5 .
Adjuvant therapies were used (probably) in all later series but it was very variable, and when reported, the stage of disease and the interventions used were not well enough characterized to attempt analysis. There were no data on performance status, quality of life, symptomatic change, or other patient reported outcomes.
Discussion
The evidence tables and figures provide an historical record of the outcomes of 50 years of lung-sparing surgery for MPM. There are no randomized studies and no direct or indirect comparison with the survival of comparable unoperated patients. The limitations on the inferences that can be drawn from retrospective case series have been previously enumerated. 34 It is of course negotiable which papers to include and which to exclude. These decisions were made in the interests of finding data rather than to fit any prior belief and we hope that we have not overlooked any publication that would cast new or further light on the research question -which is the effect of lung sparing extirpative surgery for malignant pleural mesothelioma.
As a result of applying the test that the included publications should provide data that enabled some level of analysis, exclusion of some important papers concerning PD were made. An example is the report by Grossebner et al. 35 It describes a videothoracoscopic approach with the emphasis on diagnosis, pleural fluid control and lung mobilization, all with palliative intent. This is the subject of an ongoing randomized controlled trial. 36 Also excluded was a study where patients having 'maximum debulking surgery' either EPP or PD and complex adjuvant therapy were randomized, half having photodynamic therapy. 37 As the purpose of that study was evaluation of photodynamic therapy and the surgery was mixed it was excluded from our analysis. However, other studies with primary intent of reporting one or more adjuvant therapies were included if they also included data in lung sparing surgery which could be analysed. The judgements were made on the basis of utility of the data for the present analysis. It should be emphasized that we had no patient level data and that the analyses are illustrative rather than definitive. Figure 4 shows the survival for first to fifth year after surgery and Figure 5 shows the median survival with the size of symbols proportional to the number of patients in the series. We have not attempted to produce an aggregated statistic because of the heterogeneous nature of surgery but the eye can see that there is a consistency in results among the larger series with smaller series tending to be outliers. The illustration shows that six larger series, with more than 50 and more than 100 cases included, had median survivals of 10-15 months. Does this represent longer survival than these patients would have had without resection? In Table 3 All survival data that could be extracted from the reports. Where data are stated in the paper, in text or tables, these have been used. Where the data were displayed graphically the proportion alive at 1, 2, 3, 4 and 5 years has been read from the graphs to supplement the data reported in text and tables a report of 945 patients with malignant pleural mesothelioma 38 those who had no surgery (n=387) had a mean survival of 16.8 months and those who had an exploratory thoracotomy but no resection (147/558; 31%) survived on average 17.8 months. 39 It is understood that these were patients with less favorable clinical and pathological characteristics than those selected for surgery, but they fared as well as the operated patients. The work of those deriving better staging systems is of great importance. It is noteworthy that in a series of 262 patients undergoing a range of treatments in South Africa, performance status and Butchart staging were correlated with survival across all treatment groups. 40 Clearly standardization of a form of staging generally applicable to preoperative patients (rather than relying on intra-operative or pathological evaluation) will be essential in any future trials.
Between the 1960s and the present, the time span of the 1270 operations summarized, there will have been changes in practice and case selection, and in the use of effective chemotherapy. The variety of textual accounts in Table 1 , with surgeons making intra-operative decisions on how much can be removed, illustrates the imperative to standardize the operation for any future studies if they are to have meaning and allow surgeons to compare their own with reported results, and the work of others. This is evident in the work of Waller's group in Leicester, UK. [6] [7] [8] It is also likely that any impression of longer survival in more recent series may be due to other factors such as lead time bias due to earlier detection in the modern era, stage migration with contemporary imaging, and the likely effect of reporting bias. Therefore any discernable change cannot reliably be ascribed to newer rather than earlier techniques. More sophisticated analyses with newer statistical techniques would not clarify whether there is a difference in survival attributable to any particular factor. The question remains whether any of the operations described in Table 2 make a difference to outcome.
In 1988 Alberts wrote 'Despite enthusiastic reports of response to treatment, untreated patients with malignant pleural mesothelioma may survive just as long as treated patients'. 40 The authors cited the Brompton group's analysis of surgical results in support of this contention. 33 Achatzy et al. observed 'It is interesting to note that the long-term prognosis of patients treated non-operatively was better than that of surgically treated patients. In the non-operative group, the 5-year survival was 11.4% (5 of 44 patients) whereas in the operative group, the comparable figure was 2.2% (4 of 178 patients)' and yet they concluded 'Decortication and pleurectomy, when possible, is the treatment of choice'. 32 Since lung-sparing surgery is being promoted as a clinical option for MPM patients in the modern era, knowledge of these results should be available to inform patients. If we are to move the emphasis from making an impact on survival to improving the quality of that survival, then more information is required concerning patient reported outcomes, their ability to breathe, and their quality of life.
